NCT00763529

Elocon vs Fluticasone in Localized Psoriasis (P03197)

Elocon vs Fluticasone in Localized Psoriasis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 245 (actual)
• Sponsor: Organon and Co · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is an open-label, randomized, parallel-group clinical study. The primary objective is to assess the difference in response rate between mometasone furoate cream 0.1% (once daily) vs fluticasone propionate cream 0.05% (twice daily) by the end of Day 4 and Day 8 in the management of Indian patients with localized psoriasis.

Conditions

• Psoriasis

Interventions

Type	Name	Description
DRUG	Mometasone	Mometasone furoate cream 0.1% applied once daily
DRUG	Fluticasone	Fluticasone propionate cream 0.05% applied twice daily

Timeline

• Start date: 2003-01-01
• Primary completion: 2005-01-01
• Completion: 2005-01-01
• First posted: 2008-10-01
• Last updated: 2024-08-15